Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters











Database
Language
Publication year range
1.
Chem Commun (Camb) ; 59(67): 10109-10112, 2023 Aug 17.
Article in English | MEDLINE | ID: mdl-37528768

ABSTRACT

Despite the apparent copious fluorescent probes targeting mitochondria, the development of low cytotoxic probes is still needed for improving validation of mitochondrial function assessment. Herein, we report a novel cyanine-based NIR fluorescent probe, T2, which selectively targets mitochondria with significantly low toxicity by modulating the intracellular redox status. Additionally, T2 inhibits oxidative stress-induced cell death in cortical neurons. This study provides new insight into developing low-toxic mitochondrial imaging agents by regulating redox homeostasis.


Subject(s)
Diagnostic Imaging , Oxidative Stress , Cell Death , Oxidation-Reduction , Fluorescent Dyes/toxicity , Fluorescent Dyes/metabolism , Mitochondria/metabolism
2.
Chem Commun (Camb) ; 58(78): 10941-10944, 2022 Sep 29.
Article in English | MEDLINE | ID: mdl-36082694

ABSTRACT

A new conjugate formulation, SIWV-PB-SN, based on glioblastoma (GBM)-homing SIWV tetrapeptide and an ROS-responsive prodrug is reported. SIWV-PB-SN selectively penetrates the GBM cells and releases anti-GBM drug (SN-38) via ROS-induced linker cleavage. This study presents a new insight for a more advanced therapeutic approach to overcoming GBM.


Subject(s)
Glioblastoma , Prodrugs , Cell Line, Tumor , Glioblastoma/drug therapy , Humans , Irinotecan , Prodrugs/pharmacology , Prodrugs/therapeutic use , Reactive Oxygen Species
3.
Angew Chem Int Ed Engl ; 61(36): e202206894, 2022 09 05.
Article in English | MEDLINE | ID: mdl-35789171

ABSTRACT

Peroxynitrite (ONOO- ) plays a critical role in Alzheimer's disease (AD). To reveal the ONOO- influx in AD brains, an activatable activity-based fluorescence probe Rd-DPA3 was designed by a structure-modulated strategy. Taking advantage of ONOO- -initiated two-step cascade reactions of a novel chemical trigger, Rd-DPA3 specifically responds to ONOO- in 0.3 mM of other reactive oxygen species (ROS) and varied proteins, and gives an intensive fluorescence enhancement (F/F0 =50). Moreover, with its mitochondria-targeting ability, Rd-DPA3 can be used to efficiently monitor the alternations of intracellular ONOO- levels in cerebral cells during oxidative stress. Significantly, due to NIR emission and good blood-brain barrier (BBB) crossing ability, Rd-DPA3 is suitable for in vivo imaging of cerebral ONOO- influx and illustrating an age-dependent accumulation of ONOO- in AD mice brains.


Subject(s)
Alzheimer Disease , Peroxynitrous Acid , Alzheimer Disease/diagnostic imaging , Animals , Brain/diagnostic imaging , Brain/metabolism , Fluorescence , Fluorescent Dyes , Mice
SELECTION OF CITATIONS
SEARCH DETAIL